Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Gilles Pernod

Showing results (1-10 of 97) with videos related to

Pageof 10
Sort By:
La Revue Du Praticien|May 6, 2015
[Etiologic assessment of venous thromboembolism]Gilles Pernod
Revue Medicale Suisse|March 15, 2014
[Management of major bleeding complications in patients on long-term treatment with oral anticoagulants]Gilles Pernod
La Revue Du Praticien|May 31, 2022
[Hypercoagulability in cancer des cancers]Gilles Pernod
Archives of Cardiovascular Diseases|June 17, 2014
Comments on: Laboratory tests for the management of major bleeding complications and emergency surgery in patients on long-term treatment with direct oral anticoagulants: proposals of the Working Group on Perioperative Haemostasis (GIHP): a rebuttalGilles Pernod
Journal of Vascular Surgery|December 3, 2014
Antithrombotic therapy after infrainguinal bypassMario Maufus, Gilles Pernod
Circulation|April 25, 2012
Letter by Marlu et al regarding article, "reversal of rivaroxaban and dabigatran by prothrombin complex concentrate: a randomized, placebo-controlled, crossover study in healthy subjects"Raphael Marlu, Enkelejda Hodaj, Gilles Pernod
Lancet (London, England)|May 30, 2006
Gene-gene interactions in myocardial infarctionGilles Pernod, Olivier Ormezzano, Gérald Vanzetto
Thrombosis Research|March 11, 2022
Is pulmonary embolism occurring after SARS COV-2 vaccination provoked or unprovoked?Judith Catella, Marion Joly, Gilles Pernod
Thrombosis Research|January 29, 2015
Ex vivo reversal of the anticoagulant effects of edoxaban - comments on the study by Halim et alRaphaël Marlu, Benoît Polack, Gilles Pernod
The New England Journal of Medicine|January 26, 2007
D-dimer and duration of anticoagulationGilles Pernod, Marie-Antoinette Sevestre, Jose Labarere
Pageof 10

Showing results (1-10 of 97) with videos related to

Sort By:
Pageof 10
La Revue Du Praticien|May 6, 2015
[Etiologic assessment of venous thromboembolism]Gilles Pernod
Revue Medicale Suisse|March 15, 2014
[Management of major bleeding complications in patients on long-term treatment with oral anticoagulants]Gilles Pernod
La Revue Du Praticien|May 31, 2022
[Hypercoagulability in cancer des cancers]Gilles Pernod
Archives of Cardiovascular Diseases|June 17, 2014
Comments on: Laboratory tests for the management of major bleeding complications and emergency surgery in patients on long-term treatment with direct oral anticoagulants: proposals of the Working Group on Perioperative Haemostasis (GIHP): a rebuttalGilles Pernod
Journal of Vascular Surgery|December 3, 2014
Antithrombotic therapy after infrainguinal bypassMario Maufus, Gilles Pernod
Circulation|April 25, 2012
Letter by Marlu et al regarding article, "reversal of rivaroxaban and dabigatran by prothrombin complex concentrate: a randomized, placebo-controlled, crossover study in healthy subjects"Raphael Marlu, Enkelejda Hodaj, Gilles Pernod
Lancet (London, England)|May 30, 2006
Gene-gene interactions in myocardial infarctionGilles Pernod, Olivier Ormezzano, Gérald Vanzetto
Thrombosis Research|March 11, 2022
Is pulmonary embolism occurring after SARS COV-2 vaccination provoked or unprovoked?Judith Catella, Marion Joly, Gilles Pernod
Thrombosis Research|January 29, 2015
Ex vivo reversal of the anticoagulant effects of edoxaban - comments on the study by Halim et alRaphaël Marlu, Benoît Polack, Gilles Pernod
The New England Journal of Medicine|January 26, 2007
D-dimer and duration of anticoagulationGilles Pernod, Marie-Antoinette Sevestre, Jose Labarere
Pageof 10